Skip to main content

Launch of User-Friendly Hematology Analyzers is the Best Way to Venture into the Market

The global hematology testing is perceived to be a market with high attractiveness, by the investors. Strong investments in this field aided by considerable research activities by both public and private sectors are expected to propel the growth of the market in the years that follow. In spite of having several favorable factors, investments into the market are being hindered by the slow adoption rate of expensive hematology testing devices in low income and middle-come countries of the world. The most promising way to venture into this market and gain measurable profits is through innovations and development of advanced, compact, accurate, and user-friendly hematology analyzers.

Sysmex Corporation, headquartered in Japan is catering to in-vitro diagnostics, offers wide range of hematology testing products ranging from hematology analyzers and flow cytometers to reagents, stains, controls, and calibrators. The huge product contribution of the company resulted in its market dominance in 2017 and 2018, with an overall good amount of the global market share in 2017 and 34.73% of the global market share in 2018. Following Sysmex Corporation, Abbott Laboratories was the second major contributor of the global market revenue, accounting for good rate of the total market share in 2017 and 2018, respectively.

Next to North America, Europe is the second leading contributor of the global hematology testing market. Increasing research and investments pertaining to the development technologically advanced hematology testing products coupled with significant support from both public and private sectors in terms of funding are the key driving factors for the growth of the hematology testing in Europe. Europe contributed to 23.00% of the market share in 2018. Within Europe, Germany is the leading country and Italy is expected to witness the highest CAGR during the forecast period between 2019 and 2029.



The global hematology testing market, by end user, is concentrated around hospitals, clinical testing laboratories, research institutions, and patient self-testing, among others. With the growing prevalence of blood-related disorders across the world, the need to develop advanced hematology tests is growing rapidly leading to vast technological advancement in the field of hematology.

Labels

Labels:

Comments

  1. Blog279995 March 2020 at 18:14

    According to Stanford Medical, It's indeed the one and ONLY reason women in this country get to live 10 years longer and weigh 42 pounds less than we do.

    (By the way, it really has NOTHING to do with genetics or some secret diet and EVERYTHING around "HOW" they eat.)

    P.S, I said "HOW", and not "what"...

    TAP this link to determine if this quick quiz can help you unlock your true weight loss possibility

    ReplyDelete

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...
Post a Comment
Read more

Vertical Farming Market Strategy and Growth Factor Report 2020-2026

With the exponential growth of the global population, the subsequent increase in global food demand, the decrease in agricultural land, and the depletion of limited natural resources, the need to improve agricultural yield has become critical. The upsurge in the urban population in developing countries, with improved quality of living due to high-income levels and the demand for fresh farm produce and animal protein, is bolstering the demand for crop production. The finite presence of natural resources, such as arable land and fresh water, along with falling farm yield trends in many crop categories, have encouraged crop producers and agricultural companies to introduce innovative and advanced agriculture alternatives to boost farm profitability. Read Report Overview: https://bisresearch.com/industry-report/vertical-farming-market.html Concerning the growing world population and the rising food sufficiency demand, the limited land resources won’t be sufficient to feed the ...
Post a Comment
Read more